AURITEC PHARMACEUTICALS, INC.
Last verified 2026-05-05. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $3.0Mattributed |
|---|---|
| Latest round | grant, $3.0M, 2023-09-01attributed |
| Founded | 2003 |
| Headquarters | PASADENA, California, USA |
| Industry | healthtech |
| Stage | unknown |
| Website | auritecpharma.com |
Pharmaceutical R&D company developing long-acting drug-delivery technologies for HIV prevention, contraception, and chronic-disease therapies. Targets global-health funders and partners working on HIV/AIDS, women's health, and adherence-sensitive chronic-disease therapies. Decade-plus track record formulating long-acting implants and depots that reduce dosing frequency.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2023-09-01 | grant | $3.0M | undisclosed |
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $3.0M | attributed | sbir named as publisher. No document URL on file. |
| Total raised $3.0M | attributed | sbir named as publisher. No document URL on file. |
| Company existence | self-reported | auritecpharma.com, read 2026-05-05 |
| Description | self-reported | auritecpharma.com, read 2026-05-05 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.